Prostate cancer Board decisions

The Board has determined that the Veteran's prostate cancer is not related to his service-connected prostatitis and therefore denied his claim for service connection.

The Veteran's claim for service connection for prostate cancer as a result of exposure to herbicides is being remanded due to the need for further development regarding his in-service flights and potential exposure to Vietnam.

The Board has reopened the claim for service connection for prostate cancer due to exposure to herbicides, but finds no evidence of such exposure and thus cannot grant service connection.

The appellant did not submit a timely substantive appeal with the November 2005 rating decision denying service connection for the cause of the Veteran's death.

The Board found that the reduction of the Veteran's evaluation from 100 percent to 10 percent for residuals, status post carcinoma of the prostate was proper and denied a higher rating. The Veteran's condition is currently rated at 10 percent.

The Board has remanded the appellant's claim for DIC benefits due to incorrect VCAA notice and incomplete service records. The case will be reconsidered after the necessary development is completed.

The Veteran's claims for increased ratings and service connection were denied. The RO provided the Veteran with multiple opportunities to submit evidence, but he failed to appear at scheduled VA examinations.

The Veteran's claims for service connection for various conditions, including hypertension, prostate cancer, diabetes mellitus, peripheral neuropathy of the upper and lower extremities, and a psychiatric disorder were denied. The Board found that new evidence did not raise a reasonable possibility of substantiating these claims.

The Veteran's prostate cancer is presumed to have been incurred in active military service due to exposure to herbicide agents, specifically Agent Orange, while stationed near the Korean Demilitarized Zone (DMZ).

The Board found that the Veteran's cause of death was not due to service-connected conditions or radiation exposure during service. The claim for service connection for prostate cancer is also denied.

The Veteran's initial claim for increased ratings for prostate cancer and erectile dysfunction associated with brachytherapy was granted. The prostate cancer rating is set at 10 percent from April 15, 2004, and 40 percent as of July 28, 2005. The erectile dysfunction rating remains noncompensable.

The RO discontinued the 100 percent rating for prostate cancer and assigned a 20 percent rating for residuals of prostate cancer, status post high-dose brachytherapy effective January 1, 2007. A 40 percent rating was assigned from January 8, 2009.

The Veteran's prostate cancer is not recognized as a disease specific to radiation-exposed Veterans, and the evidence does not demonstrate that his current condition is related to his active service.

The Veteran's claim is being remanded for further evaluation of his prostate cancer and its residuals, including a penile deformity resulting from the radical prostatectomy. The effective date remains unknown as no new rating has been assigned.

The Veteran's prostate cancer residuals, including urinary frequency and occasional leakage, are rated at 20 percent effective September 19, 2005.

The Veteran is granted an increased rating of 40 percent for residuals of prostate cancer effective February 7, 2008. Before that date, he was rated at 20 percent.

The Board found that the Veteran did not have service in Vietnam and thus was not exposed to herbicides. The evidence does not show any link between his time in service and any of his claimed conditions, including diabetes mellitus, stomach cancer, esophageal cancer, or prostate cancer. As such, the claims for service connection were denied.

The Veteran's death was not caused by service-connected disability, and the appellant did not meet the criteria for DIC benefits under 38 U.S.C.A. § 1318.

The Veteran's claim for service connection for prostate cancer was denied as there is no evidence of a current diagnosis of prostate cancer, and the Veteran has been diagnosed with bladder cancer instead.

The Board has determined that the Veteran's prostate cancer residuals are due to ionizing radiation exposure during service and grants service connection for this condition.